Comparison of sleep microarchitecture in screen failure subjects with insomnia complaints and randomized subjects from two phase 3 studies on insomnia disorder

INTRODUCTION: Daridorexant, a dual orexin receptor antagonist, was shown to be effective and safe in improving sleep and daytime functioning in subjects with insomnia in two Phase 3 studies. All patients screened had subjective insomnia, but many did not meet the study eligibility criteria. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Marco, T., Dauvilliers, Y., Scammell, T., Djonlagic, I., Datta, A., Zammit, G., Seboek Kinter, D., Tjiptarto, N., Donoghue, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596388/
http://dx.doi.org/10.1192/j.eurpsy.2023.612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596388/
http://dx.doi.org/10.1192/j.eurpsy.2023.612

Ejemplares similares